beyond automated ipsc reprogramming: applications for a fully automated ..
Published 5 years ago • 531 plays • Length 18:36Download video MP4
Download video MP3
Similar videos
-
43:44
achieving clinical quality for human ipsc generation and expansion
-
6:23
spotlight on ipsc reprogramming
-
5:07
how to reprogram fibroblasts into human induced pluripotent stem (ips) cells using reprorna™-oksgm
-
55:27
ipsc-derived human neurons: introduction and application
-
![automated gmp-compliant psc banking in a closed system [webinar]](https://i.ytimg.com/vi/g-V0hwt-Xe0/mqdefault.jpg)
28:34
automated gmp-compliant psc banking in a closed system [webinar]
-
7:36
the rise and fall of stem cell research
-
16:43
stem cells - the future: an introduction to ips cells
-
9:32
how to make stem cells | yamanaka factors
-
2:01
rna-based reprogramming of fibroblasts into ipscs | protocol preview
-
36:32
cellular reprogramming for the scalable production of human cells
-
![ips cells automated culture system | panasonic [20sec]](https://i.ytimg.com/vi/WyAVH-aFPi4/mqdefault.jpg)
0:22
ips cells automated culture system | panasonic [20sec]
-
32:40
webinar: stem cell reprogramming
-
39:06
development of a semi-automated closed car-t manufacturing process
-
1:06:10
modeling the human brain using induced pluripotent stem cells ipscs
-
16:51
using ips cell technology to model human neurodegenerative diseases
-
2:01
integration-free ipscs from pbmcs using episomal vectors | protocol preview
-
1:06:10
modeling the human brain using induced pluripotent stem cells ipscs 1
-
![virtual demo: automate adherent stem cell manufacturing in a closed system [webinar]](https://i.ytimg.com/vi/80jXx2hk_yE/mqdefault.jpg)
55:34
virtual demo: automate adherent stem cell manufacturing in a closed system [webinar]
-
2:39
advances in stem cell research: cell reprogramming with episomal ipsc reprogramming vectors
-
25:02
addressing the scalability of human ipsc-derived neurons for hts implementation
-
1:07:56
wscs 2013: the promise of direct reprogramming of stem cells
-
46:12
selecting the right tools to build your pluripotent stem cell based disease models